Related Pages for SRF
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Multi Straddle Analysis
- Price vs OI
- Time Series Table
- Time Series Multi Chart
- Volatility Skew
- Premium Decay
- IV - HV
- IV Intraday
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
Related News - SRF
SRF: Anticipates CB Revenue To Hit Upper Limit Of Annual Guidance Thanks To Strong Specialty Growth In H2 And Ongoing Volume Recovery.
22 Oct 2026 12:26 PM
SRF: Anticipates CB Revenue To Hit Upper Limit Of Annual Guidance Thanks To Strong Specialty Growth In H2 And Ongoing Volume Recovery.
SRF: Aims for 15-20% Revenue Growth in Chemical Operations by FY27.
22 Oct 2026 12:13 PM
SRF: Aims for 15-20% Revenue Growth in Chemical Operations by FY27.
SRF Limited: Board Greenlights ₹600 Crores For New Aluminium Foil Plant In Madhya Pradesh; First Phase Set To Finish By September 2028.
21 Oct 2026 03:03 PM
SRF Limited: Board Greenlights ₹600 Crores For New Aluminium Foil Plant In Madhya Pradesh; First Phase Set To Finish By September 2028.
SRF: Q2 CONS NET PROFIT 5.09B RUPEES VS 3.9B (YOY); EST 5.98B
21 Oct 2026 02:55 PM
SRF: Q2 CONS NET PROFIT 5.09B RUPEES VS 3.9B (YOY); EST 5.98B
SRF: Q2 EBITDA 9.45B RUPEES VS 7.74B (YOY), EST 10.55B; Q2 EBITDA MARGIN 19.3% VS 21.27% (YOY), EST 22.5%
21 Oct 2026 02:55 PM
SRF: Q2 EBITDA 9.45B RUPEES VS 7.74B (YOY), EST 10.55B; Q2 EBITDA MARGIN 19.3% VS 21.27% (YOY), EST 22.5%
SRF: Q2 REVENUE 49B RUPEES VS 36.4B (YOY); EST 46.95B
21 Oct 2026 02:56 PM
SRF: Q2 REVENUE 49B RUPEES VS 36.4B (YOY); EST 46.95B
SRF Limited : HSBC on SRF Maintains Buy with Target Price of ₹3,300 as China’s 17kt cut in R32 gas exports supports near-term India fundamentals, while quota diversion toward R134a partly offsets India’s 81kt capacity addition concern and a specialty chemicals recovery could drive momentum.
17 Sep 2026 08:50 AM
SRF Limited : HSBC on SRF Maintains Buy with Target Price of ₹3,300 as China’s 17kt cut in R32 gas exports supports near-term India fundamentals, while quota diversion toward R134a partly offsets India’s 81kt capacity addition concern and a specialty chemicals recovery could drive momentum.
SRF: HSBC on SRF Maintains Buy with Target Price of ₹3,300 as stellar Q1 earnings, strong EBIT/PAT growth, and recovery across all business segments improve growth visibility.
24 Jul 2026 09:02 AM
SRF: HSBC on SRF Maintains Buy with Target Price of ₹3,300 as stellar Q1 earnings, strong EBIT/PAT growth, and recovery across all business segments improve growth visibility.
SRF: Company Reduces Outlook During Conference Call, Expects Lower Q2 Results Compared to Q1
23 Jul 2026 11:29 AM
SRF: Company Reduces Outlook During Conference Call, Expects Lower Q2 Results Compared to Q1
SRF: Notes Decreased Volumes In Pharma Chemicals During Current Call
23 Jul 2026 11:32 AM
SRF: Notes Decreased Volumes In Pharma Chemicals During Current Call
SRF: Co's Board Greenlights ₹250 Crores Investment For BOPET Thick Film Line; Plans To Increase Capacity By 25,000 MTPA.
22 Jul 2026 02:59 PM
SRF: Co's Board Greenlights ₹250 Crores Investment For BOPET Thick Film Line; Plans To Increase Capacity By 25,000 MTPA.
SRF: Q1 CONS NET PROFIT 7.6B RUPEES VS 4.32B (YOY); EST 5.2B
22 Jul 2026 02:50 PM
SRF: Q1 CONS NET PROFIT 7.6B RUPEES VS 4.32B (YOY); EST 5.2B
SRF: Q1 REVENUE 50B RUPEES VS 38.2B (YOY)
22 Jul 2026 02:50 PM
SRF: Q1 REVENUE 50B RUPEES VS 38.2B (YOY)
SRF: Q1 EBITDA 12.36B RUPEES VS 8.3B (YOY) || Q1 EBITDA MARGIN 24.57% VS 21.7% (YOY)
22 Jul 2026 02:51 PM
SRF: Q1 EBITDA 12.36B RUPEES VS 8.3B (YOY) || Q1 EBITDA MARGIN 24.57% VS 21.7% (YOY)
SRF: Q1 CHEMICALS BUSINESS INCREASED BY 22% VS FY27 GUIDANCE OF 15-20%
22 Jul 2026 02:57 PM
SRF: Q1 CHEMICALS BUSINESS INCREASED BY 22% VS FY27 GUIDANCE OF 15-20%
SRF: Reappoints Kartik Bharat Ram As Joint Managing Director
30 Jun 2026 04:40 PM
SRF: Reappoints Kartik Bharat Ram As Joint Managing Director
SRF: HSBC initiates coverage on SRF with a Buy rating and a Target Price of ₹3390, citing strong global exposure with 50% overseas revenue and improving fundamentals in specialty chemicals and performance films expected to drive a 26% FY27–29 earnings CAGR, while highlighting risks from refrigerant gases, tariffs/anti-dumping duties, further price declines, Middle East-related raw material shortages and elevated agrochemical inventories.
13 May 2026 08:39 AM
SRF: HSBC initiates coverage on SRF with a Buy rating and a Target Price of ₹3390, citing strong global exposure with 50% overseas revenue and improving fundamentals in specialty chemicals and performance films expected to drive a 26% FY27–29 earnings CAGR, while highlighting risks from refrigerant gases, tariffs/anti-dumping duties, further price declines, Middle East-related raw material shortages and elevated agrochemical inventories.
SRF: Citi maintains a Sell on SRF with a Target Price of ₹2675 (raised from ₹2575), citing continued overhang from upcoming R32 supply additions in India through CY26/27, with high earnings sensitivity as every $1/kg change in R32 prices impacts SRF’s EBITDA by nearly 7%.
07 May 2026 09:00 AM
SRF: Citi maintains a Sell on SRF with a Target Price of ₹2675 (raised from ₹2575), citing continued overhang from upcoming R32 supply additions in India through CY26/27, with high earnings sensitivity as every $1/kg change in R32 prices impacts SRF’s EBITDA by nearly 7%.
SRF: Co. Expects 15-20% Growth Next Year Despite Unstable Global Conditions - Concall Update
06 May 2026 11:46 AM
SRF: Co. Expects 15-20% Growth Next Year Despite Unstable Global Conditions - Concall Update
SRF: Warns About Uncertainty In Global Market Situation - Concall Update
06 May 2026 11:40 AM
SRF: Warns About Uncertainty In Global Market Situation - Concall Update